Taflotan eye drops are packaged in a box of 1 plastic bottle with a capacity of 2.5ml, containing tafluprost 0.0015%. The drug is indicated to reduce high intraocular pressure in patients with open-angle glaucoma or people with increased intraocular pressure.
1. Uses of Taflotan eye drops
What is Taflotan? The ingredient of Taflotan is tafluprost, which has the ability to reduce intraocular pressure by increasing uveoscleral flow. This is an eye drop, indicated for use in cases of reducing high intraocular pressure in patients with open-angle glaucoma or increased intraocular pressure.
Contraindications: Do not use Taflotan for patients with a history of hypersensitivity to the ingredients of the drug.
2. How to use and dosage of Taflotan
2.1 How to use
How to use Taflotan eye drops as follows:
Do not use the medicine more than once a day because using the medicine more frequently can reduce the effect of lowering intraocular pressure of the medicine;
After the first instillation of the medicine for about 2 - 4 hours, intraocular pressure begins to decrease, the maximum effect is achieved after 12 hours;
Taflotan can be used in combination with other eye drops to reduce intraocular pressure. If it is necessary to use more than 1 type of eye drops, the patient should pay attention to instill each type of medicine at least 5 minutes apart.
Notes when using Taflotan eye drops:
Be careful not to let the tip of the bottle touch the eye directly to avoid contaminating the medicine;
Wipe or wash your face immediately after excess medicine solution spills onto the skin around the eyes;
When using more than 1 type of eye drops, use them at least 5 minutes apart;
Remove contact lenses before instilling Taflotan because the benzalkonium chloride in the medicine can cause discoloration of the lenses. Wait at least 15 minutes before putting contact lenses back on.
2.2 Dosage
Recommended dosage: Instill 1 drop of Taflotan eye drops into the affected eye, once a day in the evening. The specific dosage may be prescribed by the doctor for the patient depending on the patient's condition, disease progression, etc.
Overdose: There have been no reported cases of overdose. If an overdose occurs when using Taflotan, the patient needs to be treated symptomatically.
Missed dose: The patient should consult a doctor.
3. Side effects of Taflotan eye drops
When using Taflotan eye drops, patients may experience some unwanted side effects:
3.1 Common side effects
Some common side effects during the use of Taflotan:
Neurological disorders: Headache;
Skin and subcutaneous tissue disorders: Red rash, excessive hair growth on the eyelids;
Eye disorders: Abnormal eyelashes (increased thickness, length, number of eyelashes, ...), conjunctival congestion, eye irritation, eye itching, iris pigmentation, eyelid pigmentation, feeling of foreign objects in the eyes, corneal epithelial disorders, abnormal sensations in the eyes (dryness, stickiness, discomfort, ...), eye pain, blepharitis, photophobia, eye discharge, watery eyes, feeling of heaviness in the eyes, blurred vision, conjunctival edema, ...;
Tests: Positive urine protein test, increased AST concentration, increased serum potassium concentration.
3.2 Rare side effects
Some rare side effects during the use of Taflotan:
Eye disorders: Conjunctivitis, iritis, subconjunctival hemorrhage, eye itching, blepharitis, dry keratoconjunctivitis, eye pain, eye irritation, abnormal sensation in the eyes (sticky, dry, uncomfortable, ...), feeling of heaviness in the eyes or foreign objects in the eyes, eyelid dermatitis, photophobia, blurred vision, deepening of the upper eyelid sulcus, ...;
Tests: Eosinophilia, increased ALT concentration, decreased white blood cell count, increased uric acid, positive urinary glucose, increased gamma-GTP concentration, ...
When experiencing side effects of Taflotan, patients need to stop using the drug and notify the doctor or go to the nearest hospital for examination.
4. Precautions when using Taflotan
When using Taflotan eye drops, patients should note the following:
Pigmentation: Taflotan can cause changes in pigmented tissue, increasing pigmentation of the iris, eyelids and eyelashes. After stopping the drug, the pigmentation of the iris is likely to remain unchanged, and the pigmentation of the eyelids and eyelashes may recover. Therefore, patients treated with Taflotan should be informed by their doctor about the risk of hyperpigmentation. During treatment, patients with increased iris pigmentation can continue to use Taflotan but need to have regular eye examinations and check-ups;
Eyelash changes: Taflotan eye drops can gradually change the eyelashes and vellus hair in the eye. These changes include increased length, color, thickness, shape and number of eyelashes. Eyelash changes will usually disappear after stopping the drug;
Endophthalmitis: Taflotan should be used with caution in patients with endophthalmitis (uveitis, iritis) because the inflammation may become more severe;
Macular edema: Taflotan should be used with caution in patients with aphakia, pseudophakic lens with posterior capsular tear or patients with risk factors for macular edema;
Do not use Taflotan in children due to safety concerns related to increased pigmentation after long-term use;
Transient blurred vision may occur after taking Taflotan. Therefore, patients should refrain from driving or operating machinery until this symptom disappears;
Caution when using Taflotan in pregnant women: Only prescribe if the benefits outweigh the risks;
Avoid using Taflotan in breastfeeding women. If the use of the drug is necessary, the doctor should instruct the patient to stop breastfeeding during the treatment period.
5. Taflotan drug interactions
Experts have not conducted specific studies on Taflotan drug interactions in humans, because the concentration of tafluprost in the body is very low after eye drops. In clinical studies, no significant interactions were observed even when tafluprost was used in combination with timolol. However, to ensure the safety and effectiveness of the drug, patients should still inform their doctors about the drugs they are using and the diseases they are suffering from.
Taflotan eye drops are indicated for the treatment of certain eye diseases. Because the drug has the potential to cause some unwanted side effects, patients need to use the drug exactly as prescribed by the doctor, do not abuse the drug. If any signs of side effects of the drug are encountered, patients should stop using the drug, immediately notify the doctor for timely examination, diagnosis and treatment.
Follow the Vinmec International General Hospital website to learn more about health, nutrition, and beauty to protect the health of yourself and your loved ones.
To arrange an appointment, please call HOTLINE or make your reservation directly HERE. You may also download the MyVinmec app to schedule appointments faster and manage your reservations more conveniently.
